Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Extended Registry

NCT02974777 is registered in ClinicalTrials.gov with Kaiser Franz Josef Hospital as lead sponsor.

NCT NCT02974777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Extended Registry
Lead sponsor
Kaiser Franz Josef Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
Not reported
Completion date
January 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterioscleroses, platelet dysfunction due to drugs